Sponsored Links

Mylan second quarter earnings rise, but foreign exchange drags

Thu Aug 1, 2013 8:04am EDT

Aug 1 (Reuters) - Generic drugmaker Mylan Inc said on Thursday that its second-quarter earnings rose, but forecast 2013 revenue would be at the low end of an expected $7 billion to $7.4 billion range because of the weakening of India's and Japan's currencies against the dollar.

The company said that revenue in the second quarter was $1.7 billion, up from $1.69 billion a year earlier. That falls short of analyst expectations for revenue of $1.73 billion, according to Thomson Reuters I/B/E/S.

The stronger U.S. dollar brought revenue down by about 1 percent, the company said.

The company reported net income of $178 million, or 46 cents per share, up from $139 million, or 33 cents per share, a year earlier.

 
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (0)
Be the first to comment on reuters.com.
Add yours using the box above.